Randox and Ulster University team up to support athletes of the future
Randox and Ulster University team up to support athletes of the future
Randox has joined forces with Ulster University in a major university-wide sports sponsorship deal.
The investment will supply kit and equipment for 70 sports clubs across the university including basketball, GAA, hockey and soccer. Randox will also be the main sponsor of the Freshers Fayres across the four Ulster University campuses and the universities Colours Sports Awards.
Professor Alastair Adair Deputy Vice-Chancellor Ulster University said:
“Ulster University and Randox enjoy a longstanding partnership built around research, knowledge sharing, collaboration and student opportunity which reflects the leadership of both organisations in diagnostics and health research globally. We are very encouraged that one of our valued industry partners is now supporting us as we work to develop our students striving for success in the sporting world.”
Nigel Dobson, Head of Sport Services, Ulster University said:
“Ulster University is recognised as a leading university for sport on the island of Ireland, from our sporting successes to our academic excellence and world-leading research in physical activity and exercise science. This major sponsorship deal will enable us to invest in young and aspiring coaches by providing mentoring support and coach education opportunities for the coaches of the future. We look forward to working with the team at Randox as we enable the next generation of sporting stars to reach their full potential.”
Lyndsay Rodgerson Senior Recruitment Consultant, Randox Laboratories, said:
“We have worked closely with Ulster University for many years, enjoying a mutually beneficial relationship that has seen the development of a diverse range of industrial-academic opportunities.
“Our successful and ongoing partnership continues to evolve and this year alone has seen a Randox-sponsored GAA tour of China, the launch of the Randox-Ulster University-Industrial PhD Academy and the adoption of Ulster University’s Mind Your Mood initiative as Randox’s official charity partner. We are delighted that our collaboration with this renowned university has now grown to include a university-wide sports sponsorship which will continue to benefit students long in to the future.
“Randox is passionate about fostering talent – whether that be in sport or science – and about promoting health and wellbeing across the age spectrum, and we see the sponsorship as a brilliant opportunity to nurture the young sporting talents of Northern Ireland. There may be players amongst the ranks of Ulster University’s sports teams who join Randox as part of their placement year, or who take up a graduate position with us in the years to come, and we look forward to supporting these students as they thrive in both the sporting and academic spheres.”
For more information about the Randox – Ulster University partnership, please contact the Randox PR team by emailing randoxpr@randox.com
Randox announces mental health charities AWARE and Mind Your Mood as Official Charity Partners
Global healthcare company Randox Laboratories has today announced mental health charities AWARE and Mind Your Mood as its official charity partners for 2018/2019.
The main depression charity for Northern Ireland, AWARE has an established network of 24 support groups in rural and urban areas across the country, and also delivers mental health and well-being programmes into communities, schools, colleges, universities and workplaces. Mind Your Mood is an initiative designed and managed by students at Ulster University to help break down the stigma of mental health and encourage students to access support.
Randox will be fundraising for the charities through a range of events and initiatives throughout the year, including individual staff fundraising activities, the company’s annual staff fun day, Randox Fest, and its popular Christmas Raffle.
Randox Founder and Managing Director, Dr Peter FitzGerald, commented;
“Mindful of the significant impact of mental health issues on society, we are today announcing AWARE and Mind Your Mood as our charity partners for the year. Every one of us has been touched either directly or indirectly by these issues and it’s something we at Randox wish to help to address. We have for example invested significantly in research that will determine how problems with the digestive system can affect your mood, sleep and stress levels. We hope that our partnerships not only help those affected by mental ill-health across Northern Ireland, but also empower our Randox staff to take care of their own mental well-being.”
In addition to supporting AWARE and Mind Your Mood with fundraising events throughout the year, Randox has also committed to delivering mental health awareness sessions and mindfulness activities to its staff.
Inclusive of the introduction of the Mood Matters Workplace Programme, and the provision of dedicated Mental Health Mentors, Randox hopes to encourage staff to effectively manage their feelings when they’re stressed, worried or depressed, learn simple practical skills to help cope with their own challenges, and support their colleagues with theirs.
Clare Galbraith, Corporate Fundraising Officer for AWARE, commented;
“We’re delighted to have Randox on board as one of our official corporate fundraising partners this year. As a key employer in Northern Ireland with tremendous influence, the company has real potential to transform how we look at mental health and wellbeing, particularly in the workplace setting. We look forward to seeing the creative fundraising ideas they have planned for the year ahead and thank them for all their support thus far.”
Amanda Castray, Director of Campus Life, Ulster University said,
“Ulster University and Randox enjoy a longstanding partnership built around research, knowledge sharing, collaboration and student opportunity which reflects the leadership of both organisations in diagnostics and health research globally. We are very encouraged that one of our valued industry partners is now supporting us with our student-led mental health programme, Mind Your Mood. We look forward to working with the team at Randox as we promote positive mental health and wellbeing across our campuses and tackle the social stigmas associated with seeking support.”
As part of Randox’s focus this year on mental health and wellbeing, the global healthcare company will also be offering Ulster University students a discount on its revolutionary health checks for the duration of the partnership.
These health programmes are designed to find indicators of physical or mental ill-being at the earliest possible stage, to allow preventive action or treatment to be taken.
For further information about AWARE, and the opportunity to donate, please visit www.randox.com/aware/
For further information about Mind Your Mood, and the opportunity to donate, please visit www.randox.com/mind-your-mood/
For other enquiries, please contact Randox PR on 028 9442 2413 or email randoxpr@randox.com
Randox / Bosch partnership delivers game-changing device in fight against antibiotic resistance
A partnership between Randox Laboratories, the UK’s largest manufacturer of in-vitro diagnostics, and the German technology giant Bosch is changing the way doctors will treat patients with antibiotics, with the launch of a revolutionary product – the Vivalytic.
It’s estimated that 20% of antibiotics currently prescribed are unnecessary, and fuel the growing threat of global antibiotic resistance. This threatens the ability to treat common infectious diseases, and a growing number are becoming harder, and in some cases impossible, to treat. The World Health Organisation warns that without action, we are heading towards a post-antibiotic era.
This problem is being addressed by the Vivalytic. The result of a decade of R&D, it is an intuitive point-of-care analyser that, depending on the complexity of the test, will deliver results from 30 minutes: enabling doctors to select the right course of therapy faster than before. In some cases, this will be life-saving.
The first tests available on the Vivalytic are Randox’s panels for respiratory and sexually-transmitted infections*.
Using Randox’s patented Biochip Array Technology, the Respiratory Multiplex Array simultaneously reports on 22 viral and bacterial pathogens including Bordetella pertussis and parapertussis which causes whooping cough – without the need for secondary or confirmatory testing to inform clinical treatment decisions. The STI array enables the detection of 10 STIs from a single sample. Every day more than 1 million STIs are acquired, and many have mild if any symptoms at all. Identifying these infections correctly first time reduces the misuse of antibiotics and supports their targeted use.
The Managing Director of Randox Dr Peter FitzGerald commented:
“Antibiotic stewardship is a critical issue which we all have a responsibility to embrace and drive forward. This partnership is ideal, combining our expertise in molecular laboratory diagnostics with Bosch’s cutting-edge engineering. The Vivalytic is a game-changer for clinicians and patients: never before has there been this level of accessibility to this range of molecular diagnostics.”
Marc Meier, General Manager of Bosch Healthcare Solutions, a wholly owned subsidiary of Bosch Group, said:
“We are enthusiastic about having gained Randox as the first partner on our platform with two initial panels available from the start. It´s the beginning of jointly expanding the Vivalytic test portfolio for our clients. In this partnership the core competencies of Bosch in automation, miniaturization, and networking are complemented by Randox’s expertise in developing and commercializing innovative diagnostic solutions.”
Vivalytic and the panels will be presented to industry professionals for the first time at the ECCMID 2018 Congress in Madrid, Spain, in hall 10, booth 55A between 21st – 24th April.
*CE pending and FDA planned.
For further information about the Vivalytic, please contact randoxpr@randox.com
Randox Laboratories and Qnostics announce strategic partnership
Randox Laboratories and Qnostics have today announced that they have entered into a strategic partnership. The partnership will provide Randox Laboratories with access to the Qnostics molecular range of products for sales and distribution purposes, complementing the established Randox Laboratories portfolio.
Access to the Randox Laboratories commercial capabilities will enhance Qnostics’ market penetration, whilst also maintaining their presence as an independent provider of molecular quality controls and custom services.
MD of Randox Laboratories, Dr Peter FitzGerald said;
“We are delighted to have agreed a strategic partnership with Qnostics, an arrangement we see as mutually beneficial. We look forward to working together to strengthen the molecular service we provide to our global markets whilst enhancing the Qnostic brand and market penetration.”
Dr Frank Opdam, Head of Commercial of Qnostics said;
“We believe this is an ideal partnership. We look forward to working with Randox Laboratories and the growth that will result from the global access this partnership will provide to Qnostics for its expanding range of molecular quality control products.”
For further information please contact the Randox PR Team: phone 028 9442 2413 or email randoxpr@randox.com
